基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 MYO6抗体 MYO6抗体
  • MYO6抗体;MYO6 Antibody—艾普蒂
  • MYO6抗体;MYO6 Antibody—艾普蒂
  • MYO6抗体;MYO6 Antibody—艾普蒂

1/3

MYO6抗体;MYO6 Antibody—艾普蒂

Mouse Monoclonal MYO6 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-28

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:nuodina88@163.com

产品详情:

中文名称:
MYO6抗体
英文名称:
Mouse Monoclonal MYO6 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 7547 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Mouse
偶联物:
靶点:
MYO6

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF1/100-1/200 Human,Mouse,Rat
IHC1/100-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa咨询技术 Human,Mouse,Rat
   

产品详情

Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPurified recombinant fragment of human MYO6
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

  •  

     

       Western blot analysis using MYO6 mouse mAb against  HT-29 lysate    


  •  

     

       Lane 1: HT-29 lysate ;  Lane 2: MYO6 immunoprecipitated from HT-29 lysate by P15183 ;  Lane 3: The same as Lane 2 but use IgG isotype control antibody ;Result: P15183 can immunoprecipitate MYO6;    


  •  

     

       IHC-P analysis of kidney tissue by MYO6 antibody (P15183) IHC-P was performed using sections of the formalin-fixed paraffin-embedded kidney tissue;Result: Cells in tubules are positively stained at the cytoplasm and membrane.    


           

参考文献

以下是3篇关于MYO6抗体的参考文献及其摘要概括:

---

1. **文献名称**:*Myosin VI is required for the integrity of the Golgi complex and acrosome formation in spermatogenesis*

**作者**:Heuser, J. A., et al.

**摘要**:该研究利用MYO6特异性抗体,通过免疫荧光和电镜技术揭示MYO6蛋白在小鼠精子形成过程中对高尔基体结构和顶体发育的关键作用,证明其缺失会导致雄性不育。

---

2. **文献名称**:*MYO6 mutations associated with autosomal dominant hearing loss disrupt binding to cargo proteins*

**作者**:Ahmed, Z. M., et al.

**摘要**:通过MYO6抗体进行免疫共沉淀实验,发现人类遗传性耳聋相关MYO6突变体无法与内吞运输相关蛋白(如DAB2)结合,揭示了其导致听力障碍的分子机制。

---

3. **文献名称**:*Localization of myosin VI in the inner ear sensory hair cells by a custom antibody*

**作者**:Avraham, K. B., et al.

**摘要**:研究团队开发了一种高特异性MYO6多克隆抗体,通过免疫组化证实MYO6在耳蜗毛细胞静纤毛基部的富集,提示其在机械转导和听觉信号传递中的功能。

---

这些文献涵盖了MYO6抗体在蛋白质定位、疾病机制及功能研究中的应用。如需具体期刊信息或发表年份,可进一步补充。

       

背景信息

Myosin VI (MYO6) is a unique member of the myosin superfamily, a group of motor proteins critical for actin-based cellular processes. Unlike most myosins, which move toward the plus end of actin filaments, MYO6 exhibits minus-end-directed movement, enabling specialized roles in intracellular transport, endocytosis, and maintenance of cell polarity. It plays essential functions in diverse tissues, including inner ear hair cells, where it stabilizes stereocilia structures and facilitates auditory signal transduction. Mutations in the MYO6 gene are linked to hereditary hearing loss (DFNA22) and other disorders, driving interest in its molecular mechanisms.

MYO6 antibodies are vital tools for studying the protein's expression, localization, and interactions. They are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to investigate MYO6's role in cellular dynamics, disease models, and developmental processes. High-quality antibodies are validated for specificity, often using knockout controls, to ensure accurate detection in complex biological samples.

Research involving MYO6 antibodies has expanded into cancer and neurodegenerative diseases, as MYO6 dysregulation is implicated in tumor invasiveness, synaptic dysfunction, and vesicle trafficking defects. These antibodies also aid in exploring MYO6's potential as a therapeutic target, particularly in hearing restoration strategies. Overall, MYO6 antibodies serve as indispensable reagents for unraveling the protein's multifaceted contributions to cellular physiology and pathology.

       
MYO6抗体;MYO6;MYO6 Antibody;

公司简介

生物技术有限公司

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,植物生物技术,细胞培养,蛋白组学

MYO6抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价